Siegfried Hameln GmbH
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Langes Feld 13, Hameln, 31789, Germany (DEU)
- Operations here
- analysislabelmanufacturepacksterilize
- FDA identifiers
- FEI 3002807877 · DUNS 315869123
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-09-01
- VAIDrug Quality Assurance2018-04-24
- VAIDrug Quality Assurance2016-07-01
- VAIDrug Quality Assurance2014-07-25
- OAIDrug Quality Assurance2012-06-14
- VAIDrug Quality Assurance2009-11-09
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- dihydroergotamine mesylateBaxter Healthcare Corporation
- ephedrine sulfateExela Pharma Sciences, LLC
- foscarnet sodiumHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.